{"id":162541,"date":"2022-06-18T01:44:21","date_gmt":"2022-06-18T05:44:21","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/u-s-fda-clears-myco-001-for-multi-site-government-funded-trial-in-smoking-cessation\/"},"modified":"2024-08-18T11:44:44","modified_gmt":"2024-08-18T15:44:44","slug":"u-s-fda-clears-myco-001-for-multi-site-government-funded-trial-in-smoking-cessation","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/u-s-fda-clears-myco-001-for-multi-site-government-funded-trial-in-smoking-cessation.php","title":{"rendered":"U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation"},"content":{"rendered":"<p><![CDATA[DENVER, June  17, 2022  (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (\u201cMydecine\u201d or the \u201cCompany\u201d), a biotechnology aiming to transform the treatment of mental health and addiction disorders, today announced that the U.S. Food and Drug Administration (FDA) has cleared MYCO-001 in a recent Investigational New Drug (IND) application, marking the first clearance of the Company\u2019s drug product.]]><\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/17\/2464599\/0\/en\/U-S-FDA-Clears-MYCO-001-for-Multi-Site-Government-Funded-Trial-in-Smoking-Cessation.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation\">U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The rest is here: U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/u-s-fda-clears-myco-001-for-multi-site-government-funded-trial-in-smoking-cessation.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162541","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162541"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162541"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162541\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}